Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old

NCT00617851 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1507

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Lot A of Influenza virus vaccine
BIOLOGICAL: Lot B of Influenza virus vaccine
BIOLOGICAL: Lot C of Influenza virus vaccine
BIOLOGICAL: Comparator influenza virus vaccine
BIOLOGICAL: All 3 consecutive lots of influenza virus vaccine pooled

Sponsor

Novartis Vaccines